Minerva Neurosciences, Inc. (NERV)
4.17
+0.05
(+1.21%)
USD |
NASDAQ |
Sep 10, 16:00
4.17
0.00 (0.00%)
After-Hours: 18:11
Minerva Neurosciences Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2022 | 4.527 |
| March 29, 2022 | 4.312 |
| March 28, 2022 | 4.172 |
| March 25, 2022 | 4.339 |
| March 24, 2022 | 4.295 |
| March 23, 2022 | 4.231 |
| March 22, 2022 | 4.261 |
| March 21, 2022 | 4.178 |
| March 18, 2022 | 4.232 |
| March 17, 2022 | 3.857 |
| March 16, 2022 | 3.618 |
| March 15, 2022 | 3.589 |
| March 14, 2022 | 3.525 |
| March 11, 2022 | 3.695 |
| March 10, 2022 | 3.696 |
| March 09, 2022 | 3.604 |
| March 08, 2022 | 3.625 |
| March 07, 2022 | 3.398 |
| March 04, 2022 | 3.589 |
| March 03, 2022 | 3.642 |
| March 02, 2022 | 3.804 |
| March 01, 2022 | 3.700 |
| February 28, 2022 | 3.783 |
| February 25, 2022 | 3.653 |
| February 24, 2022 | 3.670 |
| Date | Value |
|---|---|
| February 23, 2022 | 3.764 |
| February 22, 2022 | 3.750 |
| February 18, 2022 | 3.966 |
| February 17, 2022 | 4.108 |
| February 16, 2022 | 4.237 |
| February 15, 2022 | 4.232 |
| February 14, 2022 | 3.750 |
| February 11, 2022 | 3.895 |
| February 10, 2022 | 4.071 |
| February 09, 2022 | 4.195 |
| February 08, 2022 | 4.098 |
| February 07, 2022 | 4.216 |
| February 04, 2022 | 4.017 |
| February 03, 2022 | 4.071 |
| February 02, 2022 | 4.232 |
| February 01, 2022 | 4.285 |
| January 31, 2022 | 4.421 |
| January 28, 2022 | 3.855 |
| January 27, 2022 | 3.963 |
| January 26, 2022 | 3.917 |
| January 25, 2022 | 3.910 |
| January 24, 2022 | 4.071 |
| January 21, 2022 | 4.519 |
| January 20, 2022 | 4.516 |
| January 19, 2022 | 4.377 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.655 |
| Alnylam Pharmaceuticals, Inc. | 24.44 |
| Anika Therapeutics, Inc. | 2.045 |
| Savara, Inc. | 7.606 |
| Vericel Corp. | 5.237 |
Price to Book Value Related Metrics
| Price | 4.17 |
| Earnings Yield | -692.4% |
| Market Cap | 196.94M |